Trial Profile
An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2013
Price :
$35
*
At a glance
- Drugs Pilsicainide (Primary)
- Indications Arrhythmias
- Focus Adverse reactions; Pharmacokinetics; Registrational
- 18 Sep 2013 New trial record